Tags: Drug.
AL-34662 is an indazole derivative drug that is being developed for the treatment of glaucoma. It acts as a selective 5-HT2A receptor agonist the same target as that of psychedelic drugs like psilocin but unlike these drugs AL-34662 was designed specifically as a peripherally selective drug which does not cross the blood–brain barrier.